Study Stopped
Insufficient resources
Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study
3 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
After locating the suspicious lesion/mass with standard of care mammography and/or ultrasound, a photoacoustic scan will be performed in the breast where the lesion is located. After the PA scan a biopsy will be performed, if clinically indicated (based on the mammogram and ultrasound only).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2014
Shorter than P25 for not_applicable breast-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2011
CompletedFirst Posted
Study publicly available on registry
January 31, 2013
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedJanuary 30, 2017
January 1, 2017
1 year
November 14, 2011
January 27, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
The lesion visibility on PAI, described using a five-level scale: 1. Not visible 2. Barely visible 3. Fair (or moderately visible) 4. Visible 5. Clearly visible.
6 months
Secondary Outcomes (1)
Measures of hypoxia in the lesion
6 months
Study Arms (1)
Photo Acoustic Imaging
EXPERIMENTALAn exploratory, single armed, pilot study designed to evaluate the feasibility of Photo Acoustic Imaging (PAI) in a clinical setting.
Interventions
Standard of Care
Eligibility Criteria
You may qualify if:
- Patients must have a breast lesion/mass found at physical examination, mammography or ultrasound (US), that has not been surgically resected
- Patients may have any of the following characteristics:
- Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer Tamoxifen)
- Breast implants
- Previous breast biopsy
- Previous breast surgery
- Previous breast cancer
- High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA) mutations, other gynecologic cancer)
- Ability to understand and the willingness to sign a written informed consent document
You may not qualify if:
- Patients who have had primary surgical excision of the suspicious finding
- Pregnant or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sanjiv Gambhir, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair, Dept. of Radiology
Study Record Dates
First Submitted
November 14, 2011
First Posted
January 31, 2013
Study Start
September 1, 2014
Primary Completion
September 1, 2015
Study Completion
March 1, 2016
Last Updated
January 30, 2017
Record last verified: 2017-01